Currently set to Index
Currently set to Follow
search
ask age2b
CART 0

Science Diabetes mellitus

ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study
November 7, 2021
0
0
Marie Pigeyre 1 2 3, Jennifer Sjaarda 1 2 4, Michael Chong 1 2 4, Sibylle Hess 5, Jackie Bosch 1 6, Salim Yusuf 1 7, Hertzel Gerstein 1 3, Guillaume Paré 8 2 4 7 Main idea: These results support the causal protective effect of ACE inhibitors on type 2 diabetes risk and may […]
Read more
Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment
November 7, 2021
0
0
Ignatios Ikonomidis 1, George Pavlidis 2, John Thymis 1, Dionysia Birba 1, Aimilianos Kalogeris 1, Foteini Kousathana 2, Aikaterini Kountouri 2, Konstantinos Balampanis 2, John Parissis 1, Ioanna Andreadou 3, Konstantinos Katogiannis 1, George Dimitriadis 2, Aristotelis Bamias 2, Efstathios Iliodromitis 1, Vaia Lambadiari Main idea: Twelve-month treatment with GLP-1RA, SGLT-2i, and their combination showed […]
Read more
Diet-induced weight loss alters hepatic glucocorticoid metabolism in type 2 diabetes mellitus
November 7, 2021
0
0
Andreas Stomby 1 2, Julia Otten 1, Mats Ryberg 1, Ruth Andrew 3, Brian R Walker 3 4, Tommy Olsson 1 Main idea: These interventions caused weight loss and improved insulin sensitivity with concomitant increases in the conversion of cortisone to cortisol, which is an estimate of hepatic HSD11B1 activity. This suggests that dysregulation of […]
Read more
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
November 7, 2021
0
0
Julio Rosenstock 1, Harpreet S Bajaj 1, Andrej Janež 1, Robert Silver 1, Kamilla Begtrup 1, Melissa V Hansen 1, Ting Jia 1, Ronald Goldenberg 1, NN1436-4383 Investigators Main idea: Once-weekly treatment with insulin icodec had glucose-lowering efficacy and a safety profile similar to those of once-daily insulin glargine U100 in patients with type 2 […]
Read more
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
November 7, 2021
0
0
Faidon Magkos 1, Mads F Hjorth 1, Arne Astrup 2 Main idea: Obesity is one of the greatest factors for the development of type 2 diabetes mellitus.  A weight reduction for 15 kg established remission in more than 80% of patients. Abstract Evidence from observational studies and randomized trials suggests that prediabetes and type 2 […]
Read more
Effect of dairy consumption and its fat content on glycemic control and cardiovascular disease risk factors in patients with type 2 diabetes: a randomized controlled study
November 7, 2021
0
0
Joanna Mitri 1 2, Shaheen Tomah 1 2, Adham Mottalib 1 2 3, Veronica Salsberg 1, Sahar Ashrafzadeh 1, David M Pober 1 2, Ahmed H Eldib 1 2, Mhd Wael Tasabehji 1 2, Osama Hamdy 1 2 Main idea: In patients with type 2 diabetes, increased dairy consumption to ≥3 servings/d compared with <3 […]
Read more
Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial
November 7, 2021
0
0
Shahrad Taheri 1, Hadeel Zaghloul 2, Odette Chagoury 3, Sara Elhadad 3, Salma Hayder Ahmed 3, Neda El Khatib 4, Rasha Abou Amona 4, Katie El Nahas 4, Noor Suleiman 5, Abdulla Alnaama 6, Abdulla Al-Hamaq 4, Mary Charlson 7, Martin T Wells 8, Samya Al-Abdulla 6, Abdul Badi Abou-Samra 5 Main idea: These findings […]
Read more
Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA 1c, in Patients With Type 2 Diabetes
November 7, 2021
0
0
Ali Muhammed Ali 1, Robert Martinez 1, Hussein Al-Jobori 1, John Adams 1, Curtis Triplitt 1, Ralph DeFronzo 2, Eugenio Cersosimo 1, Muhammad Abdul-Ghani 1 Main idea: These results demonstrate that liraglutide failed to block the increase in EGP caused by canagliflozin despite blocking the rise in plasma glucagon and preventing the decrease in plasma […]
Read more
Improvement of NRF2 gene expression and antioxidant status in patients with type 2 diabetes mellitus after supplementation with omega-3 polyunsaturated fatty acids: A double-blind randomised placebo-controlled clinical trial
November 7, 2021
0
0
Pegah Golpour 1, Mitra Nourbakhsh 2, Maryam Mazaherioun 3, Leila Janani 4, Mona Nourbakhsh 5, Parichehreh Yaghmaei 1 Main idea: Supplementation with n-3 PUFAs enhanced NRF2 gene expression and improved overall antioxidant capacity and thus might be considered beneficial in the amelioration of oxidative stress and prevention of T2DM complications. Abstract Background: Nrf2 is a […]
Read more

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.